Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyCellularComponenteuchromatin

SETD5 CECR2 DNMT3A

1.49e-0472303GO:0000791
DomainGrowth_fac_rcpt_

LTBP2 CUBN EPHA5

1.78e-03156293IPR009030
DomainCUB

TNFAIP6 CUBN

2.62e-0349292PF00431
DomainCUB

TNFAIP6 CUBN

2.72e-0350292SM00042
Domain-

TNFAIP6 CUBN

2.94e-03522922.60.120.290
DomainCUB

TNFAIP6 CUBN

3.05e-0353292PS01180
DomainCUB_dom

TNFAIP6 CUBN

3.52e-0357292IPR000859
DomainSAM_1

SASH1 EPHA5

4.98e-0368292PF00536
DomainEGF-like_CS

LTBP2 CUBN EPHA5

7.54e-03261293IPR013032
DomainEGF_CA

LTBP2 CUBN

7.85e-0386292PF07645
DomainEGF_2

LTBP2 CUBN EPHA5

7.86e-03265293PS01186
DomainTyrKc

JAK1 EPHA5

8.20e-0388292SM00219
DomainTyr_kinase_cat_dom

JAK1 EPHA5

8.20e-0388292IPR020635
DomainSAM

SASH1 EPHA5

8.20e-0388292SM00454
DomainSAM_DOMAIN

SASH1 EPHA5

9.51e-0395292PS50105
DomainPROTEIN_KINASE_TYR

JAK1 EPHA5

9.89e-0397292PS00109
DomainSAM

SASH1 EPHA5

9.89e-0397292IPR001660
DomainEGF_Ca-bd_CS

LTBP2 CUBN

9.89e-0397292IPR018097
DomainTyr_kinase_AS

JAK1 EPHA5

9.89e-0397292IPR008266
DomainEGF_CA

LTBP2 CUBN

1.03e-0299292PS01187
DomainASX_HYDROXYL

LTBP2 CUBN

1.05e-02100292PS00010
Domain-

SASH1 EPHA5

1.17e-021062921.10.150.50
DomainEGF-type_Asp/Asn_hydroxyl_site

LTBP2 CUBN

1.17e-02106292IPR000152
Pubmed

DNMT3A and TET2 dominate clonal hematopoiesis and demonstrate benign phenotypes and different genetic predispositions.

TET2 DNMT3A

7.19e-07230228655780
Pubmed

Double somatic mosaic mutations in TET2 and DNMT3A--origin of peripheral T cell lymphoma in a case.

TET2 DNMT3A

7.19e-07230225687841
Pubmed

DNA methyltransferase 3 alpha and TET methylcytosine dioxygenase 2 restrain mitochondrial DNA-mediated interferon signaling in macrophages.

TET2 DNMT3A

7.19e-07230235931086
Pubmed

Clonal hematopoiesis driven by DNMT3A and TET2 mutations: role in monocyte and macrophage biology and atherosclerotic cardiovascular disease.

TET2 DNMT3A

7.19e-07230234654019
Pubmed

DNMT3A and TET2; Potential Estimates of Generic DNA Methylation in Children and Adolescents with Obesity; Relation to Metabolic Dysregulation.

TET2 DNMT3A

7.19e-07230235066499
Pubmed

CRISPR-Mediated Gene Editing to Assess the Roles of Tet2 and Dnmt3a in Clonal Hematopoiesis and Cardiovascular Disease.

TET2 DNMT3A

7.19e-07230229728415
Pubmed

Clonal Hematopoiesis and Risk of Progression of Heart Failure With Reduced Left Ventricular Ejection Fraction.

TET2 DNMT3A

7.19e-07230233832602
Pubmed

Lineage restriction analyses in CHIP indicate myeloid bias for TET2 and multipotent stem cell origin for DNMT3A.

TET2 DNMT3A

7.19e-07230229764839
Pubmed

Mutations in TET2 and DNMT3A genes are associated with changes in global and gene-specific methylation in acute myeloid leukemia.

TET2 DNMT3A

7.19e-07230228992762
Pubmed

Clinical Implication of DNMT3A and TET2 Genes Mutations in Cytogenetically Normal Acute Myeloid Leukemia.

TET2 DNMT3A

7.19e-07230236580013
Pubmed

TET2 and DNMT3A mutations in human T-cell lymphoma.

TET2 DNMT3A

7.19e-07230222216861
Pubmed

Divergent Effects of Dnmt3a and Tet2 Mutations on Hematopoietic Progenitor Cell Fitness.

TET2 DNMT3A

7.19e-07230232220332
Pubmed

Association of Mutations Contributing to Clonal Hematopoiesis With Prognosis in Chronic Ischemic Heart Failure.

TET2 DNMT3A

7.19e-07230230566180
Pubmed

DNMT3A and TET2 compete and cooperate to repress lineage-specific transcription factors in hematopoietic stem cells.

TET2 DNMT3A

7.19e-07230227428748
Pubmed

Uncompromised 10-year survival of oldest old carrying somatic mutations in DNMT3A and TET2.

TET2 DNMT3A

7.19e-07230226825711
Pubmed

TET2 and DNMT3A Mutations Exert Divergent Effects on DNA Repair and Sensitivity of Leukemia Cells to PARP Inhibitors.

TET2 DNMT3A

7.19e-07230234215619
Pubmed

DNMT3A(R882H) mutant and Tet2 inactivation cooperate in the deregulation of DNA methylation control to induce lymphoid malignancies in mice.

TET2 DNMT3A

7.19e-07230226876596
Pubmed

Loss-of-function mutations in Dnmt3a and Tet2 lead to accelerated atherosclerosis and concordant macrophage phenotypes.

TET2 DNMT3A

7.19e-07230239196062
Pubmed

Prevalence and prognostic significance of DNMT3A- and TET2- clonal haematopoiesis-driver mutations in patients presenting with ST-segment elevation myocardial infarction.

TET2 DNMT3A

7.19e-07230235339897
Pubmed

Clonal haematopoiesis in chronic ischaemic heart failure: prognostic role of clone size for DNMT3A- and TET2-driver gene mutations.

TET2 DNMT3A

7.19e-07230233241418
Pubmed

TET2 and DNMT3A mutations and exceptional response to 4'-thio-2'-deoxycytidine in human solid tumor models.

TET2 DNMT3A

7.19e-07230234039392
Pubmed

Acute myeloid leukemia derived from lympho-myeloid clonal hematopoiesis.

TET2 DNMT3A

2.16e-06330227881874
Pubmed

DNA methylation disruption reshapes the hematopoietic differentiation landscape.

TET2 DNMT3A

2.16e-06330232203468
Pubmed

Measurable residual disease of canonical versus non-canonical DNMT3A, TET2, or ASXL1 mutations in AML at stem cell transplantation.

TET2 DNMT3A

2.16e-06330234267355
Pubmed

Reduction in DNA methyltransferases and alteration of DNA methylation pattern associate with mouse skin ageing.

TET2 DNMT3A

2.16e-06330224645644
Pubmed

[Relationship between DTA Mutations and Thromboembolism in Patients with Myeloproliferative Neoplasms].

TET2 DNMT3A

2.16e-06330238926973
Pubmed

Telomere Attrition and Clonal Hematopoiesis of Indeterminate Potential in Cardiovascular Disease.

TET2 DNMT3A

2.16e-06330234576030
Pubmed

Epigenetic Changes in Neoplastic Mast Cells and Potential Impact in Mastocytosis.

TET2 DNMT3A

2.16e-06330233803981
Pubmed

Concurrent STAT3, DNMT3A, and TET2 mutations in T-LGL leukemia with molecularly distinct clonal hematopoiesis of indeterminate potential.

TET2 DNMT3A

2.16e-06330227761930
Pubmed

Epigenetic Regulation of Hepatic Lipid Metabolism by DNA Methylation.

TET2 DNMT3A

2.16e-06330237282749
Pubmed

Decreased DNA methyltransferases expression is associated with coronary artery lesion formation in Kawasaki disease.

TET2 DNMT3A

2.16e-06330231171909
Pubmed

Hematopoietic clonal dominance, stem cell mutations, and evolutionary pattern of JAK2V617F allele burden in polycythemia vera.

TET2 DNMT3A

2.16e-06330225082530
Pubmed

TET2-mutant clonal hematopoiesis and risk of gout.

TET2 DNMT3A

2.16e-06330235714308
Pubmed

Differential expression of DNA methyltransferases and demethylases among the various testicular germ cell tumor subtypes.

TET2 DNMT3A

2.16e-06330232957806
Pubmed

Clonal haematopoiesis of indeterminate potential and atrial fibrillation: an east Asian cohort study.

TET2 DNMT3A

2.16e-06330238231881
Pubmed

Overexpression of Arginase 1 is linked to DNMT3A and TET2 mutations in lower-grade myelodysplastic syndromes and chronic myelomonocytic leukemia.

TET2 DNMT3A

2.16e-06330229227812
Pubmed

HIV is associated with an increased risk of age-related clonal hematopoiesis among older adults.

TET2 DNMT3A

2.16e-06330234099923
Pubmed

Blastic plasmacytoid dendritic cell neoplasm with unusual morphology, MYC rearrangement and TET2 and DNMT3A mutations.

TET2 DNMT3A

2.16e-06330229411884
Pubmed

Combined heterozygosity of FLT3 ITD, TET2, and DNMT3A results in aggressive leukemia.

TET2 DNMT3A

2.16e-06330236073548
Pubmed

DNMT1 in Six2 Progenitor Cells Is Essential for Transposable Element Silencing and Kidney Development.

TET2 DNMT3A

4.31e-06430230850438
Pubmed

Single nucleotide polymorphism array lesions, TET2, DNMT3A, ASXL1 and CBL mutations are present in systemic mastocytosis.

TET2 DNMT3A

4.31e-06430222905207
Pubmed

Cooperating gene mutations in childhood acute myeloid leukemia with special reference on mutations of ASXL1, TET2, IDH1, IDH2, and DNMT3A.

TET2 DNMT3A

7.18e-06530223365461
Pubmed

Dnmt3a-mutated clonal hematopoiesis promotes osteoporosis.

TET2 DNMT3A

7.18e-06530234698806
Pubmed

Mutations of the epigenetics-modifying gene (DNMT3a, TET2, IDH1/2) at diagnosis may induce FLT3-ITD at relapse in de novo acute myeloid leukemia.

TET2 DNMT3A

7.18e-06530223135354
Pubmed

Clonal Hematopoiesis of Indeterminate Potential With Loss of Tet2 Enhances Risk for Atrial Fibrillation Through Nlrp3 Inflammasome Activation.

TET2 DNMT3A

7.18e-06530238357791
Pubmed

Genome-wide scan of copy number variation in late-onset Alzheimer's disease.

TOMM40 SASH1

1.51e-05730220061627
Pubmed

Editing activity for eliminating mischarged tRNAs is essential in mammalian mitochondria.

TOMM40 SDHA

1.51e-05730229228266
Pubmed

DNA methyltransferase 3b regulates articular cartilage homeostasis by altering metabolism.

TET2 DNMT3A

2.01e-05830228614801
Pubmed

TET1 regulates fibroblast growth factor 8 transcription in gonadotropin releasing hormone neurons.

TET2 DNMT3A

2.58e-05930231361780
Pubmed

Dysregulation of the TET family of epigenetic regulators in lymphoid and myeloid malignancies.

TET2 DNMT3A

3.22e-051030231467060
Pubmed

A mutation in the tuft mouse disrupts TET1 activity and alters the expression of genes that are crucial for neural tube closure.

TET2 CECR2

5.58e-051330226989192
Pubmed

TET2 catalyzes active DNA demethylation of the Sry promoter and enhances its expression.

TET2 DNMT3A

7.50e-051530231530896
Pubmed

EHMT2 directs DNA methylation for efficient gene silencing in mouse embryos.

TET2 DNMT3A

7.50e-051530226576615
Pubmed

An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.

PXN AGMAT GIGYF1 ANK3 ECT2 SETD5 DIS3

1.06e-04132130727173435
Pubmed

Oct4 Methylation-Mediated Silencing As an Epigenetic Barrier Preventing Müller Glia Dedifferentiation in a Murine Model of Retinal Injury.

TET2 DNMT3A

1.09e-041830227895551
Pubmed

Dynamics of mitochondrial DNA nucleoids regulated by mitochondrial fission is essential for maintenance of homogeneously active mitochondria during neonatal heart development.

TOMM40 SDHA

1.96e-042430225348719
Pubmed

Catalog of mRNA expression patterns for DNA methylating and demethylating genes in developing mouse lower urinary tract.

TET2 DNMT3A

1.96e-042430223920106
Pubmed

Meta-analysis of genome-wide association studies of adult height in East Asians identifies 17 novel loci.

TET2 LTBP2 DNMT3A

2.20e-0413630325429064
Pubmed

Genome-wide association studies in an isolated founder population from the Pacific Island of Kosrae.

TOMM40 CUBN

3.97e-043430219197348
Pubmed

Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation.

TOMM40 GIGYF1 SCAF8 DIS3

6.15e-0445730432344865
Pubmed

Excess of ovarian nerve growth factor impairs embryonic development and causes reproductive and metabolic dysfunction in adult female mice.

TET2 DNMT3A

7.59e-044730232892421
Pubmed

An association study of 45 folate-related genes in spina bifida: Involvement of cubilin (CUBN) and tRNA aspartic acid methyltransferase 1 (TRDMT1).

CUBN DNMT3A

8.25e-044930219161160
GeneFamilySterile alpha motif domain containing

SASH1 EPHA5

4.20e-0388202760
ToppCellcontrol-Epithelial-Ionocyte|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

LTBP2 ATP6V0D2 ADCY5 EPHA5

4.44e-061653045cfba9a46bd8ceeca74a6493057b4d38af6b06fe
ToppCellNS-control-d_0-4-Epithelial-Ionocyte|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

LTBP2 ATP6V0D2 ADCY5 EPHA5

4.54e-061663046d9fb239f69ba519844f593c00d515e1aac4ff50
ToppCellcontrol-Epithelial-Ionocyte|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

LTBP2 ATP6V0D2 ADCY5 EPHA5

4.77e-06168304327b02f19f4a8607c033203824fdc60a1254331f
ToppCellNS-moderate-d_16-33-Epithelial-Ionocyte|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

LTBP2 ATP6V0D2 ADCY5 EPHA5

6.26e-061803048af8b4af2dc72223ac71fc027e0d4280c5dd81f8
ToppCell5'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

LTBP2 ATP6V0D2 ADCY5 EPHA5

6.40e-061813042b53a65ca5616a7b9f64232c3e0b7212d1e2f063
ToppCell5'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic-ionocyte|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

LTBP2 ATP6V0D2 ADCY5 EPHA5

6.40e-061813046aef84616e8d2faf54b7e9e6cd02f33c3066dabc
ToppCell5'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte-Ionocyte_L.0.7.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

LTBP2 ATP6V0D2 ADCY5 EPHA5

6.40e-0618130440df0afcb6848202da54670e84f22d7c3a515d01
ToppCell5'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

LTBP2 ATP6V0D2 ADCY5 EPHA5

6.40e-0618130440d3829ae4aaf81e8616c3499ff8933137fc1cc4
ToppCellNS-critical-d_07-13-Epithelial-Ionocyte|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

LTBP2 ATP6V0D2 ADCY5 EPHA5

6.68e-06183304ba43bca2b45be1008eebd3f033cecb061fb3a966
ToppCellcritical-Epithelial-Ionocyte|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

LTBP2 ATP6V0D2 ADCY5 EPHA5

6.83e-0618430458d36577eff814d46d72f031f3533d71549e3d6e
ToppCellrenal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

LTBP2 SIM2 CECR2 PPM1E

7.28e-06187304b93cf4dfe8ffb89348ee7bccc9f284189f7240a2
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

LTBP2 SIM2 CECR2 PPM1E

7.28e-061873047ea8731288e2a99f45e3958590ee1d76f49ae888
ToppCellmoderate-Epithelial-Ionocyte|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

LTBP2 ATP6V0D2 ADCY5 EPHA5

7.28e-061873043e3fe2d5712a0ac477cddefe56705d4b8d8f7eac
ToppCellLA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper

JPH2 ANK3 PPM1E EPHA5

7.43e-061883046d249fe92d51a19da19ec14bb2262d394255d577
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

LTBP2 SIM2 CECR2 PPM1E

7.43e-061883042ee64bc73a2251fd9f374be759b442cf4ed0d19e
ToppCellcritical-Epithelial-Ionocyte|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

LTBP2 ATP6V0D2 ADCY5 EPHA5

7.75e-0619030405a2c3549b68f49081723bf35db14974274419d5
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

LTBP2 SIM2 CECR2 PPM1E

7.75e-061903043dcadabbefe0128a5f30ab51234f049ab4d870c6
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

LTBP2 SIM2 CECR2 PPM1E

7.75e-06190304cc17ab84a9328124f146951c06be3eff9650d9fd
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

LTBP2 SIM2 CECR2 PPM1E

7.91e-06191304963f4f2e852bbb4faf070aafb0d368297abacd3b
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

LTBP2 SIM2 CECR2 PPM1E

8.08e-06192304562df5e87038c500dd3a003fe5374cb31946b145
ToppCellTCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Undifferentiated_Pleomorphic_Sarcoma-7|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9

ATP6V0D2 LCN1 EPHA5

8.43e-05127303c4809d8502f460370f824719d69b13b400a2b202
ToppCellChildren_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor

JPH2 LTBP2 ADCY5

1.46e-041533031524557514668f515ac1bbe847611f564b265b42
ToppCellIonocyte|World / shred by cell class for nasal brushing

LTBP2 ATP6V0D2 ADCY5

1.49e-041543036b78fb0c96fc7b5e901c39b3424f4aa8d0a6b9cf
ToppCellfacs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SIM2 CECR2 EPHA5

1.67e-04160303c381ec6be8cf887861cc18f831a20db42f953fe1
ToppCellfacs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SIM2 CECR2 EPHA5

1.67e-0416030325c8f3d2a6d14ff0ca0b965fce89d3ff22f40585
ToppCellAdult-Mesenchymal-airway_smooth_muscle_cell-D122|Adult / Lineage, Cell type, age group and donor

JPH2 LTBP2 ADCY5

1.70e-0416130364891f6f2ee1693c8481e951b9346e2f92d602e3
ToppCelldroplet-Lung-immune-endo-depleted-3m-Lymphocytic-Zbtb32+_B|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ABHD18 ECT2 CECR2

1.70e-04161303249c2b97cc25de5053f5048ee354615df49b2081
ToppCellFetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

JPH2 LTBP2 ADCY5

1.76e-0416330351dee6c21cbeca4e17d1cc386e203f0c403089e8
ToppCell356C-Myeloid-Monocyte-CD16+_Monocyte|356C / Donor, Lineage, Cell class and subclass (all cells)

TET2 ECT2 DNMT3A

1.83e-0416530335a6de30438de364ccca948fc932da541a69ef89
ToppCellPBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k)

EEF2K ZNF716 CUBN

1.93e-04168303ca94b29c1030484143a77f2df06dad74d2c6136e
ToppCellNS-critical-d_16-33-Epithelial-Ionocyte|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

LTBP2 ATP6V0D2 ADCY5

1.93e-041683036a233045638cb83dab64789b996b7598c325001e
ToppCellIonocyte-iono-1|World / Class top

ATP6V0D2 ADCY5 EPHA5

1.96e-041693034b68bcb4b5fc3cd2db23cd4edace7444aa2d605c
ToppCellTCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-6|TCGA-Liver / Sample_Type by Project: Shred V9

JPH2 LTBP2 SASH1

1.96e-04169303e992530776cab922d0360b275fb9cb8bd0017b06
ToppCellfacs-Marrow-B-cells-18m-Lymphocytic-BM_CD4_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ATP6V0D2 CUBN ANK3

2.03e-041713036f49537f8d3cf18e65aa999fec32ed347ce2da3e
ToppCell3'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature-ENCC/glia_Progenitor|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

TOMM40 PPM1E EPHA5

2.03e-04171303b51bbeacb172e8b5de519ada85543d7ae9914b3c
ToppCellfacs-Marrow-B-cells-18m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ATP6V0D2 CUBN ANK3

2.03e-04171303ab97ae2b127a585f170f028f1c475cdd1b0cdea5
ToppCellBronchial_Brush-Epithelial-Ionocytes|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X

LTBP2 ATP6V0D2 ADCY5

2.10e-04173303e1de849dcd96063136bdac87e050ddbd55cabdcc
ToppCellBronchial_Brush-Epithelial-Ionocytes|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X

LTBP2 ATP6V0D2 ADCY5

2.10e-04173303f2a8f4918c1fb68d98bc3f33cd624de0f0f11e06
ToppCellfacs-Lung-24m-Mesenchymal-myofibroblast|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

JPH2 LTBP2 PPM1E

2.14e-04174303a7ade7372e83edd4e3983e77f8417b51f0b47340
ToppCellNS-moderate-d_0-4-Epithelial-Ionocyte|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

LTBP2 ATP6V0D2 ADCY5

2.17e-04175303a1e0a15c69211d6db2edeb101476f0f6e08b90c8
ToppCellNS-moderate-d_07-13-Epithelial-Ionocyte|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

LTBP2 ATP6V0D2 ADCY5

2.25e-0417730399500aed584f793aaf308f8afbf5d1c6a9b4ee55
ToppCell3'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

LTBP2 ATP6V0D2 ADCY5

2.25e-041773036d89042bda8e244babb68929e84b25edcb545a77
ToppCell3'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte-Ionocyte_L.0.7.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

LTBP2 ATP6V0D2 ADCY5

2.25e-04177303daaccf1249dcf816df4caca695a944f53078291a
ToppCellfacs-Thymus-Epithelium-3m-Myeloid|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CUBN CECR2 PPM1E

2.25e-041773030e9e44119653abfd270e602e5e477a15e774638f
ToppCellfacs-Thymus-Epithelium-3m-Myeloid-macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CUBN CECR2 PPM1E

2.25e-04177303c2b8a3a149d70f77612759dea34df9e43953c566
ToppCellChildren_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor

JPH2 LTBP2 ADCY5

2.25e-04177303b59967219f7d874805768e247c0eb2bc4d4420c8
ToppCellfacs-Thymus-Epithelium-3m-Myeloid-macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CUBN CECR2 PPM1E

2.25e-04177303384f841aa7b2d05815af7885e481f5affc55d897
ToppCell3'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

LTBP2 ATP6V0D2 ADCY5

2.25e-04177303c5a16f984c836dbf7d0faf061677844167ab612a
ToppCell3'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic-ionocyte|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

LTBP2 ATP6V0D2 ADCY5

2.25e-04177303338bdda26796bf4e16072878c070212d1006cf57
ToppCellfacs-Lung-EPCAM-3m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

LTBP2 TNFAIP6 DIS3

2.29e-0417830327497dbfcf9bb4dd0bf7caa0bd78c7e85f5c18ee
ToppCellfacs-Lung-EPCAM-3m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

LTBP2 TNFAIP6 DIS3

2.29e-04178303d348a9550db940d204706529759dc51e30506b5f
ToppCellNS-critical-LOC-Epithelial-Ionocyte|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

LTBP2 ATP6V0D2 ADCY5

2.32e-0417930365a96bee7bc28f5bfc20f0fd92bcc0ab2eb5e06c
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

SIM2 ADCY5 PPM1E

2.36e-04180303a17dbe03597b81e7a1fe2bf2d23e59e55c615a2a
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

SIM2 ADCY5 PPM1E

2.36e-04180303eee71184ebed2694d3e60f579a44b3cf7dd2cd35
ToppCellFetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

JPH2 LTBP2 ADCY5

2.40e-0418130325915e2500430a902db37d79a749ce2990b69810
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group

AGMAT LTBP2 CUBN

2.40e-04181303c80ffa2ded5975a88e9a1a7d333196f95237bf0a
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

SIM2 CECR2 PPM1E

2.40e-0418130322363c5835dd6cef8f895ab9362e0837d92b15b1
ToppCellrenal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

SIM2 SASH1 ADCY5

2.44e-04182303eb138aa1dca9373f1586600f258df06dcf56d81f
ToppCellsaliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Granulocytic-Neutrophil-Neu_c1-IL1B|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

TET2 ZNF627 SIM2

2.44e-04182303dc32f8f6a3b13918eb8e93c018f5823d86344080
ToppCellcellseq-Epithelial-Epithelial_Neuro-Secretory-Ionocyte|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

ATP6V0D2 ADCY5 EPHA5

2.44e-041823036e7dac78dc030f74e546b9f6db07556e9bb13ac2
ToppCellcellseq-Epithelial-Epithelial_Neuro-Secretory-Ionocyte-Ionocyte|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

ATP6V0D2 ADCY5 EPHA5

2.44e-04182303cd972d30519db706477c6b0c901165b81b74abed
ToppCellwk_15-18-Mesenchymal-Myofibro_&_SMC-Early_airway_SMC_2|wk_15-18 / Celltypes from embryonic and fetal-stage human lung

JPH2 LTBP2 ADCY5

2.48e-04183303a1d4f25e13f5b9e92a9ca0a804a7bed5df8fb2fe
ToppCellfacs-Lung-EPCAM-24m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

JPH2 LTBP2 PPM1E

2.48e-041833030e8fb371d8eac777451c76f41d53577f5dfb740d
ToppCellfacs-Lung-EPCAM-24m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

JPH2 LTBP2 PPM1E

2.48e-04183303cbc3b00faa7e4e0dbbbc8ee105467c65241c7470
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

SIM2 CECR2 PPM1E

2.52e-04184303d33de57876817050b294f2ecb0a4eb0634cfa7f0
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

SIM2 CECR2 PPM1E

2.52e-041843038fd8bd3d28d0ee6f0ef1f14e354d8eaf63a8081b
ToppCellrenal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

LTBP2 SIM2 CECR2

2.52e-04184303e8238fe58f94b4f5700ab7f343fb06ea61e899a9
ToppCellrenal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

SIM2 SASH1 ADCY5

2.60e-04186303f0c8de4f6ae9047b9108a47a2af8c5f42bc103b0
ToppCellrenal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

SIM2 SASH1 ADCY5

2.64e-04187303c31130fc2f9f882944b2ba366a034a03f051c4b9
ToppCelldroplet-Heart-4Chambers-21m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

JPH2 ANK3 ADCY5

2.64e-041873038ff9f771d10c372d771c92dfa9006aa81aec4681
ToppCellPericytes-HP_01|World / lung cells shred on cell class, cell subclass, sample id

ZNF716 LTBP2 ADCY5

2.64e-0418730335f25780d113f60bf4c13749013c09612ee4ff41
ToppCellrenal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

SIM2 SASH1 ADCY5

2.68e-04188303af740fa78542438fdff627ea1f74f4eee43316be
ToppCellnormal_Lung-Fibroblasts-Smooth_muscle_cells|normal_Lung / Location, Cell class and cell subclass

JPH2 LTBP2 ADCY5

2.68e-04188303fd70fb89570f014d1299c60fe017dc09f24e57c6
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

SIM2 CECR2 PPM1E

2.68e-041883033cee9916399e2e7580cecbcbb27424a71e7e7ac0
ToppCellmoderate-Epithelial-Ionocyte|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

LTBP2 ATP6V0D2 ADCY5

2.72e-041893036011b747e27d61d222380a7bffdd921a68e9b657
ToppCellCOPD-Myeloid-cMonocyte|Myeloid / Disease state, Lineage and Cell class

PXN TET2 TNFAIP6

2.72e-041893036294691231c7d38707323cf31578a107d3b2c622
ToppCellMesenchymal-airway_smooth_muscle_cell|World / Lineage, Cell type, age group and donor

JPH2 LTBP2 ADCY5

2.77e-04190303645e56b02edc3702c7db917b8ecd5eed0decaf71
ToppCellPSB-critical-LOC-Epithelial-Ionocyte|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

LTBP2 ATP6V0D2 ADCY5

2.81e-041913038f4637e801554e2343b974fe7794f01dd2151418
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

JPH2 LTBP2 ADCY5

2.81e-0419130304c4d454b57e29a8d1dcdeb4678ce71bdc29b77b
ToppCelldroplet-Lung-18m-Mesenchymal-myofibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

JPH2 LTBP2 ADCY5

2.85e-041923032cc712186e37fb21a964c032765c36a8b4a852cf
ToppCellwk_20-22-Mesenchymal-Myofibro_&_SMC-Vascular_SMC_2|wk_20-22 / Celltypes from embryonic and fetal-stage human lung

JPH2 LTBP2 ADCY5

2.85e-04192303a7d08416f07f29ad920168a3b52ddf992f263bf4
ToppCellP28-Mesenchymal-myocytic_cell-vascular_associated_smooth_muscle_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

JPH2 LTBP2 ADCY5

2.85e-0419230387c7780cf72f4c204f2a5f6655309d47a23c08ae
ToppCellTransplant_Alveoli_and_parenchyma-Mesenchymal-Smooth_muscle|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X

JPH2 LTBP2 ADCY5

2.90e-041933039104b572d9c3c99080e4b7455993fbb944bf117d
ToppCell5'-Adult-SmallIntestine-Epithelial-mature_enterocytic-Paneth|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

AGMAT TNFAIP6 CUBN

2.94e-041943032f6e62a4ec8707bd5a16c0734c5131af55207ea2
ToppCellCOVID-19-Heart-CM_1|Heart / Disease (COVID-19 only), tissue and cell type

JPH2 ANK3 ADCY5

2.99e-04195303f1ef50331eda8f1239dba6ea970df4eaccf032f1
ToppCellTracheal-10x5prime-Epithelial-Epi_airway_neuro-secretory|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

ATP6V0D2 ADCY5 EPHA5

3.03e-04196303a4cc02ea41479d24044bd2ca6441f85d683c0ca9
ToppCell356C-Fibroblasts-Fibroblast-K_(Pericytes)|356C / Donor, Lineage, Cell class and subclass (all cells)

JPH2 LTBP2 ADCY5

3.03e-04196303a5cc4f76e1a3825aaccba9a686d7da6f7e4300ff
ToppCell356C-Fibroblasts-Fibroblast-K_(Pericytes)-|356C / Donor, Lineage, Cell class and subclass (all cells)

JPH2 LTBP2 ADCY5

3.03e-04196303476812fc1422aca8010d771eff11fa6081f15a2d
ToppCell3'-Distal_airway-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Smooth_muscle|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

JPH2 LTBP2 ADCY5

3.03e-0419630369ad90a429af4dad5a45556544224001ebcb1607
ToppCellP15-Mesenchymal-myocytic_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

LTBP2 TNFAIP6 ADCY5

3.03e-0419630341ae5b0d81ad09a6663335d899b4a1e4976c3b62
ToppCell3'-Distal_airway-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Smooth_muscle-Smooth_muscle_L.2.3.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

JPH2 LTBP2 ADCY5

3.03e-041963034da96672a9c72268cfcc82d61eb3caae6e02d4c4
ToppCell3'-Distal_airway-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

JPH2 LTBP2 ADCY5

3.03e-04196303f78951b460913866d092ba92af70ea76a2afa73e
ToppCellTracheal-10x5prime-Epithelial-Epi_airway_neuro-secretory-Ionocyte_n_Brush|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

ATP6V0D2 ADCY5 EPHA5

3.03e-0419630350aaca81b593ff71790bb75403b2e4c3ab03a6d2
ToppCelldistal-mesenchymal-Vascular_Smooth_Muscle-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

JPH2 LTBP2 ADCY5

3.08e-04197303da653dc7d216e202f390e5ab0245f243e3ed213b
ToppCellcellseq-Mesenchymal-Myocytic-Myocytic_2|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

JPH2 LTBP2 ADCY5

3.12e-04198303c7075dce915ab8387309fcb12c5f6a17d4100cda
ToppCelldistal-2-mesenchymal-Vascular_Smooth_Muscle|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

JPH2 LTBP2 ADCY5

3.12e-04198303ce05ede69c167b2294630709bb0c223483a6ef75
ToppCellbackground-Hepatic_Stellate_cells|background / Sample and Cell Type and Tumor Cluster (all cells)

LTBP2 ANK3 ADCY5

3.12e-04198303bd11b0e9e80449aab979a02c1023e0638c431c7c
ToppCellcellseq-Mesenchymal-Myocytic|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

JPH2 LTBP2 ADCY5

3.17e-0419930320e62a7029fa0d214244cdf2a481fc5d78290438
ToppCellParenchymal-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

JPH2 LTBP2 ADCY5

3.17e-041993037c272a1aa7f3e931ad5d20809719d85b3bce4cb0
ToppCelldistal-2-mesenchymal-Airway_Smooth_Muscle|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

JPH2 LTBP2 ADCY5

3.17e-04199303af226a6c50747dad9ca696463e715913b3ac17c0
DrugFolic acid [59-30-3]; Down 200; 9uM; MCF7; HT_HG-U133A

PXN SASH1 ANK3 ABHD18 DNMT3A

5.51e-061973057201_DN
DiseaseAngioimmunoblastic Lymphadenopathy

TET2 DNMT3A

5.99e-064302C0020981
DiseaseLeukemia, Myelomonocytic, Chronic

TET2 DNMT3A

1.50e-056302C0023480
DiseasePolycythemia Vera

JAK1 TET2

2.79e-058302C0032463
DiseasePeripheral T-Cell Lymphoma

TET2 DNMT3A

4.47e-0510302C0079774
Diseasestomach cancer (is_implicated_in)

JAK1 TET2 DNMT3A

5.39e-0572303DOID:10534 (is_implicated_in)
DiseaseT-cell acute lymphoblastic leukemia (is_implicated_in)

JAK1 DNMT3A

5.46e-0511302DOID:5603 (is_implicated_in)
Diseasesevere acute respiratory syndrome, COVID-19

PXN TOMM40 LTBP2 ATP6V0D2 CECR2

8.13e-05447305EFO_0000694, MONDO_0100096
Diseaseautoimmune thyroid disease

JAK1 GIGYF1 SASH1

2.84e-04126303EFO_0006812
DiseaseSezary Syndrome

TET2 DNMT3A

3.45e-0427302C0036920
Diseaselung non-small cell carcinoma (is_implicated_in)

JAK1 TET2 SDHA

3.78e-04139303DOID:3908 (is_implicated_in)
Diseasemyelodysplastic syndrome (is_implicated_in)

TET2 DNMT3A

4.27e-0430302DOID:0050908 (is_implicated_in)
Diseasediabetic nephropathy

JAK1 SASH1 SCAF8

4.73e-04150303EFO_0000401
Diseaselymphocyte percentage of leukocytes

TET2 JPH2 ADCY5 CECR2 DNMT3A

5.12e-04665305EFO_0007993
Diseaselymphocyte count

JAK1 TET2 JPH2 LTBP2 GIGYF1 ADCY5 DNMT3A

5.43e-041464307EFO_0004587
Diseaseautoimmune disease

JAK1 GIGYF1 SASH1

7.16e-04173303EFO_0005140
DiseaseLeukemia, Myelocytic, Acute

JAK1 TET2 DNMT3A

7.16e-04173303C0023467
DiseaseNeoplasm Recurrence, Local

TET2 DNMT3A

7.23e-0439302C0027643
Diseasecolorectal cancer, endometrial neoplasm

TET2 SCAF8

8.39e-0442302EFO_0004230, MONDO_0005575
DiseaseHypermetropia, Myopia

CUBN ADCY5 PPM1E

9.24e-04189303HP_0000540, HP_0000545
DiseaseAcute Promyelocytic Leukemia

TET2 DNMT3A

1.01e-0346302C0023487
DiseaseCardiomyopathy

JPH2 SDHA

1.05e-0347302cv:C0878544
Diseaseacute myeloid leukemia (is_marker_for)

TET2 DNMT3A

1.14e-0349302DOID:9119 (is_marker_for)
DiseaseC-reactive protein measurement

JAK1 PXN TOMM40 ANK3 SETD5 ADCY5

1.18e-031206306EFO_0004458
Diseasewaist-hip ratio

TET2 TOMM40 LTBP2 ANK3 ADCY5 DNMT3A

1.28e-031226306EFO_0004343

Protein segments in the cluster

PeptideGeneStartEntry
CGHKGTYGLLRRRED

DNMT3A

586

Q9Y6K1
EECGGHVRYLPRQSG

EPHA5

406

P54756
PGCEIRYLEGGHISA

ABHD18

391

Q0P651
EPGCGGERNAYLKEH

ADCY5

621

O95622
EGPIYRCQEEGLGHF

CECR2

1406

Q9BXF3
QGGKYLPLGDERCTH

ECT2

296

Q9H8V3
LGEGHFGKVELCRYD

JAK1

881

P23458
YGCTTLPDGHREEGK

JPH2

326

Q9BR39
RCGFEEGGAGPRKEH

GIGYF1

176

O75420
DSDGQHPRCKRGLGY

GPATCH3

441

Q96I76
IFYCEGELHGKPVRG

LCN1

116

P31025
RAIGDAEHKPYICGD

PPM1E

401

Q8WY54
GPEGFHEKDGKAYCR

PXN

451

P49023
GHEDAPLRGRYCGTD

CUBN

1686

O60494
REYVVKEGDHPGGLL

ANK3

2931

Q12955
LEEYDAQEGHCRPRG

LTBP2

1376

Q14767
VRYHEGGRFCEKGEE

EEF2K

531

O00418
EREHRVLPVYGGPKG

SCAF8

1101

Q9UPN6
IREGRGCGPEKDHVY

SDHA

351

P31040
YGREDFKPRVGSHVG

PPP1R32

36

Q7Z5V6
CGHYREEPALGPAKA

SIM2

546

Q14190
VGDRKPLHLDGGYCS

SETD5

1006

Q9C0A6
GEKLYHGAPFRRCVD

AGMAT

196

Q9BSE5
REHYLRDDIGCGAPG

DIS3

21

Q9Y2L1
DVHGFVGRYCGDELP

TNFAIP6

201

P98066
RIHTGEKPYTCEERG

ZNF716

261

A6NP11
VRERTHPGGKPYDCK

ZNF627

156

Q7L945
EPYSDKHGRCGIPEA

SASH1

1111

O94885
LGGELVYHRRPGEEG

TOMM40

231

O96008
YEHRAPECRLGLKEG

TET2

1351

Q6N021
VDHGYLEGLVRGCKA

ATP6V0D2

11

Q8N8Y2